Superstring Capital Management’s Cabaletta Bio CABA Stock Holding History

Superstring Capital Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.87M	Sell	1,066,239 -1,187,311	-53%	-$3.3M	2.05%	22
2025 Q4	$4.94M	Buy	2,253,550 +709,025	+46%	+$1.76M	2.64%	14
2025 Q3	$3.61M	Buy	1,544,525 +483,761	+46%	+$830K	3.56%	12
2025 Q2	$1.61M	Buy	1,060,764 +601,792	+131%	+$938K	1.91%	18
2025 Q1	$636K	Sell	458,972 -363,321	-44%	-$774K	0.76%	27
2024 Q4	$1.87M	Buy	822,293 +690,498	+524%	+$2.42M	1.62%	18
2024 Q3	$622K	Sell	131,795 -8,100	-6%	-$46.9K	0.54%	23
2024 Q2	$1.05M	Sell	139,895 -150,902	-52%	-$1.85M	1.32%	22
2024 Q1	$4.96M	Buy	+290,797	New	+$6.24M	3.28%	12

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Superstring Capital Management's CABA Position: Q1 2026 in Review

Superstring Capital Management reduced its Cabaletta Bio (CABA) stake by 53% in Q1 2026, selling an estimated $3.3M and leaving 1,066,239 shares worth $2.87M. The position accounts for 2.05% of the portfolio, ranked #22.

Superstring Capital Management first reported a position in CABA in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.96M in Q1 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

Superstring Capital Management held 1,066,239 shares of Cabaletta Bio worth $2.87M as of Q1 2026.
Superstring Capital Management sold 1,187,311 Cabaletta Bio shares in Q1 2026, an estimated $3.3M.
Cabaletta Bio made up 2.05% of Superstring Capital Management's portfolio in Q1 2026, its #22 holding.
Superstring Capital Management first reported a position in Cabaletta Bio in Q1 2024 and has held it in 9 quarters since.
Superstring Capital Management's Cabaletta Bio position peaked at $4.96M in Q1 2024.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Superstring Capital Management's 13F filing for Q1 2026, filed 14 May 2026.